ArticleBritish journal of cancer2019

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.

Vera Gorbunova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.